|
UGT1A1 without BSA assay
|
BAO_0010175 |
|
|
UGT1A6 with BSA assay
|
BAO_0010178 |
|
|
UGT1A4 without BSA assay
|
BAO_0010177 |
|
|
CYP time dependent inhibition single point assay
|
BAO_0010172 |
|
|
CYP time-dependent inhibition assay
|
BAO_0010169 |
|
|
CYP time dependent inhibition kinact/KI assay
|
BAO_0010171 |
|
|
UGT1A1 with BSA assay
|
BAO_0010174 |
|
|
enzyme inhibition assay
|
BAO_0010157 |
|
|
tropomyosin-related kinase B receptor agonist
|
CHEBI_140489 |
|
|
UGT1A6 without BSA assay
|
BAO_0010179 |
|
|
neurokinin-3 receptor antagonist
|
CHEBI_140482 |
|
|
neuropeptide Y2 receptor agonist
|
CHEBI_138168 |
|
|
urethral stricture
|
DOID_1829 |
|
|
idiopathic generalized epilepsy
|
DOID_1827 |
|
|
UGT1A9 without BSA assay
|
BAO_0010181 |
|
|
UGT1A9 with BSA assay
|
BAO_0010180 |
|
|
childhood absence epilepsy
|
DOID_1825 |
|
|
permeable
|
PATO_0000982 |
|
|
response to drug
|
GO_0042493 |
|
|
CYP3A4 inhibition assay
|
BAO_0010165 |
|
